Safety of multicomponent meningococcal group B vaccine
The Lancet Child & Adolescent Health in conversation with - Un pódcast de The Lancet Group
Categorías:
Philip Bryan joins The Lancet Child & Adolescent Health to discuss the safety of multicomponent meningococcal group B vaccine (4CMenB) in the UK’s infant immunisation programme.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
